Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 17.95
-0.65 (-3.49%)
At close: Jun 26, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €134.92 million as of June 26, 2026. Its market cap has increased by 346.06% in one year.
Market Cap
134.92M
Enterprise Value
132.72M
Revenue
9.69M
Ranking
n/a
PE Ratio
46.58
Stock Price
€17.95
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 134.92M, an increase of 777.90%. That is a compound annual growth rate of 66.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 134.92M | 109.73% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.43B |
| Laboratorios Farmaceuticos Rovi | 3.04B |
| Almirall | 2.42B |
| Faes Farma | 1.43B |
| Clínica Baviera | 906.65M |
| Oryzon Genomics | 246.65M |
| Laboratorio Reig Jofre | 220.63M |
| Prim, S.A. | 218.63M |